Target Name: FJX1
NCBI ID: G24147
Review Report on FJX1 Target / Biomarker Content of Review Report on FJX1 Target / Biomarker
FJX1
Other Name(s): four jointed box 1 | FJX1_HUMAN | FLJ25593 | four-jointed box kinase 1 | Four-jointed protein homolog | Putative secreted ligand homologous to fjx1 | Four-jointed box protein 1 | four-jointed protein homolog | FLJ22416 | putative secreted ligand homologous to fjx1 | Four-jointed box kinase 1

FJX1: A Protein Implicated in Cell Division and Disease

FJX1 (Four Jointed Box 1) is a protein that is expressed in various tissues of the human body. It is a key player in the regulation of cell division and has been implicated in the development and progression of various diseases. Although the exact function of FJX1 is not yet fully understood, research has shown that it plays a crucial role in several cellular processes that are essential for human health. In this article, we will explore the potential implications of FJX1 as a drug target and its potential as a biomarker for various diseases.

The Importance of FJX1
FJX1 is a member of the superfamily of proteins known as the FJX family. This family has been identified in many different organisms, including mammals, and is characterized by the presence of four distinct domains: an N-terminal transmembrane domain, a coiled-coil domain, a catalytic domain, and a C-terminal T-cell receptor (TCR) domain. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various cell surface receptors, while the coiled-coil domain is responsible for the protein's ability to adopt a specific shape. The catalytic domain is responsible for the protein's catalytic activity, and the C-terminal TCR domain is responsible for the protein's ability to interact with the TCR, a protein that is expressed in many different cell types and is involved in cell signaling.

One of the most significant functions of FJX1 is its role in cell division. FJX1 is a critical regulator of mitosis, a process that is essential for the development and progression of tissues in the body. During mitosis, FJX1 helps to ensure that the correct number of chromosomes are replicated and that they are properly distributed during cell division. Without FJX1's intervention, mitosis would not proceed correctly, and cells would be unable to divide properly, leading to the development of cancer.

In addition to its role in cell division, FJX1 has also been shown to play a critical role in the regulation of cell signaling pathways. FJX1 has been shown to interact with various signaling proteins, including T cell factor (TGF-β), which is a protein that plays a critical role in the regulation of cell growth, differentiation, and survival. TGF-β has been shown to interact with FJX1 and to promote the formation of T-cells, a type of white blood cell that is involved in immune responses.

FJX1's Role in Disease
The role of FJX1 in disease is still being fully understood, but research has shown that it is involved in the development and progression of several diseases. For example, studies have shown that FJX1 is involved in the development of cancer, both in humans and in animals. In addition, FJX1 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

One of the most promising areas of research is the use of FJX1 as a drug target. By targeting FJX1 with drugs, researchers hope to be able to treat a variety of diseases that are currently untreatable or have a high risk of side effects. This is because FJX1 is involved in many different cellular processes that are essential for human health, and manipulating these processes can have a significant impact on a person's overall health.

FJX1 has also been shown to be a potential biomarker for several diseases. For example, studies have shown that FJX1 is involved in the regulation of cell division and that it is expressed in the brains of individuals with Alzheimer's disease. This suggests that FJX1 may be a useful biomarker for

Protein Name: Four-jointed Box Kinase 1

Functions: Acts as an inhibitor of dendrite extension and branching

The "FJX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FJX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FKBP10 | FKBP11 | FKBP14 | FKBP15 | FKBP1A | FKBP1A-SDCBP2 | FKBP1B | FKBP1C | FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11